Intervention Effects of Jianpi Liqi Huoxue Decoction (健脾理气活血汤) on Lipid Peroxidative Liver Injury by Alcohol

Objective: To study the intervention effects of Jianpi Liqi Huoxue Decoction ( 健脾理气活血汤, JLHD) on lipid peroxidative liver injury induced by alcohol. Methods: The rat alcoholic model of liver disease (ALD) induced by Lieber-DeCarli liquid diet was established. Thirty-two male SD rats were randomly divided into 4 groups: the normal group ( n = 5), the control group ( n = 9), the model group ( n = 9) and the JLHD group (n = 9). From the 4th week after modeling, the rats were given JLHD or distilled water by gastrogavage respectively, and the samples of blood and liver tissues were taken out from the rats for determination by the end of the 8th week. The hepatic pathological changes were observed with HE staining; the liver injury related indices, including activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum, γ-glutamyl transpeptidase (γ-GT) activity and triglyceride (TG) content in liver tissues, as well as the lipid peroxidation related indices, including malonaldehyde (MDA) content and nitric oxide synthase (NOS) activity in liver tissue, serum Fe2 level, and the anti-peroxidation capacity related indices, including superoxide dismutase (SOD) activity, glutathion ( GSH) content and reactive oxygen species (antiROS) activity in liver tissues were determined. Results: ( 1 ) There were obvious figures of fatty degeneration and inflammatory infiltration in liver tissues of the model group. As compared with the control group, in the model group, the activity of ALT and AST, and Fe2 content in serum, γ-GT and NOS activity, TG and MDA content in liver tissues were significantly higher ( P＜0.01 ), while the activity of SOD, GSH and anti-ROS in liver tissues were significantly lower ( P＜0.01 ). (2) The fatty degeneration and inflammatory infiltration of liver tissues in the JLHD group were significantly lessen as compared with those in the model group; and the abnormalities of all the indexes revealed in the model rats were restored to certain extent in the JLHD group,and especially significant were the levels of ALT activity, MDA content and Fe2 , which were nearly normal.Conclusion: JLHD has significant effects against alcoholic liver injury, the acting mechanism of which is likely to be related with its anti-lipid peroxidative effect.     

健脾和胃汤治疗功能消化不良脾胃气虚证临床研究

[目的]观察健脾和胃汤对脾胃气虚型功能性消化不良(FD)的疗效。[方法]将100例FD患者随机分为2组,治疗组50例服用健脾和胃汤,对照组50例服用吗丁啉,分别于治疗前与治疗4周后进行评分比较疗效。[结果]总有效率治疗组为86%,对照组为70%。总有效率两组比较,差异非常显著(P<0·01)。[结论]健脾和胃汤对脾胃气虚型FD有明显疗效。     

补阳还五汤对脑缺血后中性粒细胞浸润及ICAM-1表达的影响

目的观察补阳还五汤对脑缺血再灌注后中性粒细胞浸润和ICAM-1表达的影响。方法术前7天开始罐胃,然后用线栓法诱导大鼠大脑中动脉阻塞模型,再灌24h后采用神经症状评分和梗死周边区存活神经元数评价脑损伤情况,用髓质过氧化物酶(MPO)和ICAM-1免疫组化方法,评价中性粒细胞浸润和ICAM-1表达情况。结果缺血90min再灌24h后,补阳还五汤能显著改善神经症状(P<0·05或P<0·01),增加缺血半球皮层周边区存活神经元数(P<0·05或P<0·01)。与模型组比较,补阳还五汤显著减少缺血半球皮层MPO阳性细胞数(P<0·01)和ICAM-1阳性血管数(P<0·01)。结论补阳还五汤对脑缺血损伤有保护作用,并能减少中性粒细胞浸润和ICAM-1表达。     

扶正化瘀胶囊抗肝纤维化的临床疗效和作用机制

正虚血瘀是肝纤维化的基本病机,扶正化瘀胶囊是针对此基本病机制成的抗肝纤维化药物。十多年来的临床和实验研究发现,该药可通过保护肝细胞、减轻肝损伤、抑制肝纤维化的形成等多种作用机制,来发挥其在抗肝纤维化、逆转肝纤维化、改善肝功能等方面的临床疗效。扶正化瘀胶囊是一个作用机制明确,值得临床大力推广的安全有效的抗肝纤维化药物。     

中西医结合治疗细菌性肝脓肿临床观察

目的：观察抗生素、厌氧治疗、局部穿刺引流合用中药“银鱼角消脓汤”治疗细菌性肝脓肿的疗效。方法：对临床诊断细菌性肝脓肿患者66例随机分为两组。治疗组44例用中西医结合治疗，对照组22例用单纯西医治疗。观察两组总有效率及体温复常、疼痛消失、血象复常、脓肿消失、住院时间五项临床指标。结果：治疗组总有效率95．5％，明显高于对照组的77．3％（P〈0．05），临床五项指标治疗组均优于对照组。结论：中西医结合治疗细菌性肝脓肿比单纯西医治疗更有效。     

消瘀通列汤治疗慢性盆腔疼痛综合征临床研究

目的：观察“消瘀通列汤”治疗慢性疼痛综合征（CPPS）的疗效及NIH—CPSI评分。方法：据NIH前列腺炎综合征分类标准，选择CPPS病例186例，根据EPSRT分成Ⅲa和Ⅲb两组。给予“消瘀通列汤”治疗，治疗前及治疗后每月作EPSRT常规及NIH—CPSI评分进行疗效评价。结果：3个疗程后Ⅲa组显效率41．1％，总有效率82．2％；Ⅲb组显效率51．9％，总有效率86．1％。经统计分析，两组疗效差异有显著性意义（P〈0．05）。每个疗程结束后，两组NIH—CPSI各类得分均有明显改善（P〈0．001或P〈0．01）。Ⅲa组WBC计数评分，除第1、2疗程有明显减少外，第3疗程开始无明显变化。结论：“消瘀通列汤”能有效改善慢性盆腔疼痛综合征临床症状，提高生活质量。可能减轻盆腔内静脉充血。     

活血化瘀药物治疗外伤性前房出血的探讨

目的:观察活血化瘀药物治疗外伤性前房出血的临床疗效。方法:将136例外伤性前房出血患者回顾分析并分两组进行对照治疗,对照组用单纯西医治疗,治疗组用西医治疗并活血化瘀药物治疗。结果:治疗组有效率为96.8% ,对照组为87.0% ,两组比较差异有显著性,P<0.05。活血化瘀药物有迅速止血,改善血循环,促进毛细血管代谢功能的恢复,减少并发症,迅速恢复视力很有功效。结论:活血化瘀药物可能成为治疗3、4级前房出血的理想药物     

甲心安煎剂对甲状腺素性心脏肥大大鼠心肌胶原含量的影响

目的 探讨甲心安煎剂治疗甲状腺素性心脏肥大的机制。方法将清洁级SD大鼠40只分为4组，即正常组、模型组、甲心安高剂量和低剂量治疗组各10只。正常组与模型组每日灌服纯化水2 mL，高剂量组每日灌服甲心安原液(含生药4 g·mL^-1)，低剂量组灌服甲心安稀释液(将原液加纯化水稀释至含生药2 g·mL^-1)，连续给药10 d。实验第11天取标本检测指标。结果模型组左心室重量及与体重之比均高于正常组(P＜0.01)，心肌胶原含量及 Ⅰ/Ⅲ 胶原比例均较正常组高(P＜0.01)。与之相反，经过甲心安煎剂干预后，治疗组无论低剂量或高剂量，其上述指标均较模型组低(P＜0.01)。结论甲心安煎剂能改善甲状腺素引起的心肌肥厚，降低重构心肌中的胶原含量，并调整优化心肌中 Ⅰ/Ⅲ 胶原比例。     

益气清络方治疗类风湿关节炎的机制探讨

目的观察中药益气清络方对胶原性关节炎大鼠滑膜细胞产生的细胞因子的影响,探讨益气清络方治疗类风湿关节炎的机制。方法使用含药物血清的培养基培养胶原性关节炎大鼠滑膜细胞,用酶联免疫吸附试验(ELISA)法测定上清液中白细胞介素(IL)-1、肿瘤坏死因子(TNF)-α、基质金属蛋白酶(M M P)3、前列腺素E2(PGE2)的含量。结果益气清络方可以减少滑膜细胞产生的IL-1、TN F-α、PG E2的含量。结论益气清络方具有抗炎和调节免疫的作用。     

气相色谱-质谱联用分析黄连、黄芩、白芍合煎液中挥发性成分

目的:定性分析黄连阿胶汤中黄连、黄芩、白芍单煎液与合煎液中的挥发性成分,研究其对合煎液中挥发性成分的归属以及在煎煮过程中可能发生的变化.方法:分别用石油醚萃取黄连、黄芩、白芍3味药的单煎液与合煎液,浓缩萃取物并定容至1 mL,使用Agilent GC-MS色质联用仪和HP-5 MS毛细管柱对样品进行分析.柱温程序为50℃保温5 min,8℃/min,升温至250℃.结果:共鉴定出了19个主要化合物.结论:除19号峰外,单煎液中的挥发性成分均在合煎液中检出.